谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

First-in-Human Evaluation of Site-Specifically Labeled 89Zr-Pertuzumab in Patients with HER2-Positive Breast Cancer.

Randy Yeh,Joseph A. O'Donoghue,Vetri Sudar Jayaprakasam,Audrey Mauguen,Ryan Min, Sue Park, Julia P. Brockway,Jacqueline F. Bromberg,W. Iris Zhi,Mark E. Robson,Rachel Sanford,Shanu Modi,Brian J. Agnew,Serge K. Lyashchenko,Jason S. Lewis,Gary A. Ulaner,Brian M. Zeglis

JOURNAL OF NUCLEAR MEDICINE（2024）

引用 4|浏览35
关键词
breast cancer,HER2,immuno-PET,radioimmunoconjugates
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要